AngioDynamics (ANGO) Reports In-Line Q4 EPS, Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.37 -0.16%
EPS Growth %: -200.0%
Financial Fact:
Gross profit: 45.03M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -200.0%
Financial Fact:
Gross profit: 45.03M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $87 million versus the consensus estimate of $82.92 million.
GUIDANCE:
AngioDynamics sees FY2023 EPS of $0.01-$0.06, versus the consensus of $0.08. AngioDynamics sees FY2023 revenue of $342-348 million, versus the consensus of $338 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
